VitaSpring Biomedical Co. Ltd.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-415.4K | $-774.9K | $-1.1M | $-4.2M | $909.6K | $425.4K | $6.9K | $-22.4K |
| Depreciation & Amortization | — | $10.0K | $15.1K | — | — | — | $450 | $450 |
| Depreciation | $10.0K | $10.0K | $15.1K | $15.1K | $8.4K | $0 | $450 | $450 |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $0 | $109.9K | $164.9K | $190.4K | $167.2K | $434.2K | — | — |
| Net Cash from Operating Activities | $-2.7K | $-14.7K | $-34.9K | $-77.6K | $-269.6K | $-42.1K | $-105 | $-34.2K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | $0 | $73.0K | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | $0 | $-73.0K | — | — | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $4.5K | $14.9K | $5.3K | $0 | $50.0K | $87.5K | $0 | $29.1K |
| Net Change in Cash | — | — | — | — | — | $45.4K | $-105 | $-5.1K |
| Free Cash Flow | — | — | — | $-77.6K | $-342.6K | — | — | — |